Plante Moran Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Plante Moran Financial Advisors, LLC

$997 Million
Q2 2024

A detailed history of Plante Moran Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 2,134 shares of BMY stock, worth $113,507. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,134

Previous 2,134 -0.0%

Holding current value

$113,507

Previous $115,000 23.48%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $2,255 - $2,556	-47 Reduced 2.15%	2,134 $115,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $12,944 - $15,445	-267 Reduced 10.91%	2,181 $111,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $2,778 - $3,107	-48 Reduced 1.92%	2,448 $142,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $53,452 - $59,350	839 Added 50.63%	2,496 $159,000
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $3,219 - $3,651	-49 Reduced 2.87%	1,657 $114,000
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $1,712 - $2,027	25 Added 1.49%	1,706 $122,000
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $32 - $19,056	248 Added 17.31%	1,681 $119,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $60,419 - $66,543	-832 Reduced 36.73%	1,433 $110,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $9,713 - $11,647	-158 Reduced 6.52%	2,265 $165,000
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $8,956 - $10,440	167 Added 7.4%	2,423 $151,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $326,079 - $355,101	-5,267 Reduced 70.01%	2,256 $151,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $39,579 - $44,515	667 Added 9.73%	7,523 $475,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $201,166 - $227,958	3,484 Added 103.32%	6,856 $425,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $1,722 - $1,909	30 Added 0.9%	3,372 $203,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $9,867 - $11,536	-180 Reduced 5.11%	3,342 $197,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $5,985 - $8,698	129 Added 3.8%	3,522 $196,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $49,406 - $64,446	1,004 Added 42.03%	3,393 $218,000
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $17,108 - $20,284	400 Added 20.11%	2,389 $121,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $13,536 - $16,140	-300 Reduced 13.11%	1,989 $95,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $45,736 - $59,309	-938 Reduced 29.07%	2,289 $119,000
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $53,755 - $60,631	974 Added 43.23%	3,227 $200,000
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $41,586 - $51,832	-823 Reduced 26.76%	2,253 $125,000
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $6,830 - $7,863	-114 Reduced 3.57%	3,076 $195,000
Q4 2017 Feb 01, 2018	BUY	$59.94 - $65.35 $34,165 - $37,249	570 Added 21.76%	3,190 $195,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $144,702 - $166,998	2,620	2,620 $167,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.

Account

Plante Moran Financial Advisors, LLC Bristol Myers Squibb CO Transaction History